Contribute Try STAT+ Today

The vagus nerve, also known as the “wandering nerve,” winds a path all around your torso, intersecting with everything from the heart to the lungs to the digestive tract. That makes it a natural target for a wide range of therapeutic interventions: In the late ’90s, the Food and Drug Administration cleared the first surgically implantable devices to stimulate the vagus nerve, and today they’re used to treat medication-resistant cases of depression and epilepsy.

After weaving its way through your body, the vagus nerve ultimately ends up in your cranium, passing up through your neck and branching off to whisper past the outer edge of your ear. Which is where some companies are hoping they can make an impact without implants.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.